192 related articles for article (PubMed ID: 37473527)
1. Dihydroartemisinin inhibits EMT of glioma via gene BASP1 in extrachromosomal DNA.
Que Z; Zhou Z; Liu S; Zheng W; Lei B
Biochem Biophys Res Commun; 2023 Oct; 675():130-138. PubMed ID: 37473527
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway.
Wu H; Li X; Feng M; Yao L; Deng Z; Zao G; Zhou Y; Chen S; Du Z
Oncol Rep; 2018 Dec; 40(6):3285-3296. PubMed ID: 30272353
[TBL] [Abstract][Full Text] [Related]
3. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
[TBL] [Abstract][Full Text] [Related]
4. Dihydroartemisinin prompts amplification of photodynamic therapy-induced reactive oxygen species to exhaust Na/H exchanger 1-mediated glioma cells invasion and migration.
Hou K; Liu J; Du J; Mi S; Ma S; Ba Y; Ji H; Li B; Hu S
J Photochem Photobiol B; 2021 Jun; 219():112192. PubMed ID: 34000476
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4 inhibits glioma cell migration, invasion and epithelial-to-mesenchymal transition through GLP-1R/sirt3 pathway.
Nie ZJ; Zhang YG; Chang YH; Li QY; Zhang YL
Biomed Pharmacother; 2018 Oct; 106():1364-1369. PubMed ID: 30119208
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.
Bao Z; Chen L; Guo S
J Cell Biochem; 2019 Jun; 120(6):10205-10214. PubMed ID: 30592329
[TBL] [Abstract][Full Text] [Related]
7. β-Asarone Inhibits Invasion and EMT in Human Glioma U251 Cells by Suppressing Splicing Factor HnRNP A2/B1.
Li L; Wu M; Wang C; Yu Z; Wang H; Qi H; Xu X
Molecules; 2018 Mar; 23(3):. PubMed ID: 29547514
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2.
Li J; Yuan J; Yuan X; Zhao J; Zhang Z; Weng L; Liu J
Int J Oncol; 2016 Feb; 48(2):541-50. PubMed ID: 26648487
[TBL] [Abstract][Full Text] [Related]
9. Echinacoside (ECH) suppresses proliferation, migration, and invasion of human glioblastoma cells by inhibiting Skp2-triggered epithelial-mesenchymal transition (EMT).
Shi S; Qin Y; Chen D; Deng Y; Yin J; Liu S; Yu H; Huang H; Chen C; Wu Y; Zou D; Wang Z
Eur J Pharmacol; 2022 Oct; 932():175176. PubMed ID: 35995211
[TBL] [Abstract][Full Text] [Related]
10. CACNA2D3 is downregulated in gliomas and functions as a tumor suppressor.
Jin Y; Cui D; Ren J; Wang K; Zeng T; Gao L
Mol Carcinog; 2017 Mar; 56(3):945-959. PubMed ID: 27583705
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
Li J; Li Q; Lin L; Wang R; Chen L; Du W; Jiang C; Li R
BMC Neurol; 2018 Aug; 18(1):133. PubMed ID: 30170559
[TBL] [Abstract][Full Text] [Related]
12. Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling.
Que Z; Wang P; Hu Y; Xue Y; Liu X; Qu C; Ma J; Liu Y
Pharmacol Res; 2017 May; 119():72-88. PubMed ID: 28111262
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of TRIM47 inhibits glioma cell proliferation, migration and invasion through the inactivation of Wnt/β-catenin pathway.
Chen L; Li M; Li Q; Xu M; Zhong W
Mol Cell Probes; 2020 Oct; 53():101623. PubMed ID: 32603762
[TBL] [Abstract][Full Text] [Related]
14. The role of transcriptional coactivator TAZ in gliomas.
Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
[TBL] [Abstract][Full Text] [Related]
15. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
[TBL] [Abstract][Full Text] [Related]
16. NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.
Ma H; Li T; Tao Z; Hai L; Tong L; Yi L; Abeysekera IR; Liu P; Xie Y; Li J; Yuan F; Zhang C; Yang Y; Ming H; Yu S; Yang X
J Cell Physiol; 2019 Feb; 234(2):1630-1642. PubMed ID: 30159893
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.
Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981
[TBL] [Abstract][Full Text] [Related]
18. The Role Played by SLUG, an Epithelial-Mesenchymal Transition Factor, in Invasion and Therapeutic Resistance of Malignant Glioma.
Oh SJ; Ahn EJ; Kim O; Kim D; Jung TY; Jung S; Lee JH; Kim KK; Kim H; Kim EH; Lee KH; Moon KS
Cell Mol Neurobiol; 2019 Aug; 39(6):769-782. PubMed ID: 31011939
[TBL] [Abstract][Full Text] [Related]
19. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J
J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT).
Zhang G; Feng W; Wu J
Biomed Pharmacother; 2020 May; 125():109768. PubMed ID: 32106387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]